SCRS COVID-19 Resource Center

2021 Summit and COVID-19 Plan

The Summits provide a unique venue where sites, sponsors, CRO executives and regulators join together and share trends and best practices, communicate and collaborate about the latest knowledge, and develop new partnerships through sessions, workshops, focus groups and networking opportunities.

The COVID-19 pandemic continues to make an impact on the clinical research industry, and on each of us personally and professionally. As national and global efforts to contain the virus are underway, the impact on attendees, speakers and exhibiting organizations continues.

To ensure the safety of our community, the Oncology Site Solutions Summit, European Site Solutions Summit and Asia-PAC Site Solutions Summit will be virtual event experiences.

We look forward to hosting you in Hollywood, Florida October 1-3, 2021 for the 17th annual Global Sites Solutions Summit. SCRS will continuously monitor the situation globally as the safety of Summit attendees and our commitment to offering an engaging and educational conference is of paramount importance.

Visit the website for additional information.

SCRS Advocates for Sites

COVID-19 Vaccine Distribution Access for Clinical Research Professionals – ASTHO
December 22, 2020

COVID-19 Vaccine Distribution Access for Clinical Research Professionals – NGA
December 22, 2020

SCRS Calls on Sponsors to Release Holdback Funds in Response to COVID-19
April 2, 2020

Clinical Trial Conduct Guidance

Learn More About COVID-19 Vaccines From the FDA
See the evidence for each COVID-19 vaccine and the reasoning behind the FDA’s emergency use authorizations.
March 24, 2021

Coronavirus (COVID-19) Update: February 23, 2021
February 23, 2021

Coronavirus (COVID-19) Update: FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
Suite of Guidances Addresses Vaccines, Diagnostics and Therapeutics
February 22, 2021

FDA COVID-19 Pandemic Recovery and Preparedness Plan (PREPP) Iniative
Ways to adapt our COVID-19 response to build resilience for the future.
January 13, 2021

Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency
Guidance for Industry, Investigators, and Institutional Review Boards
December 4, 2020

Emergency Use Authorization for Vaccines to Prevent COVID-19
Guidance for Industry
October 2020

Development and Licensure of Vaccines to Prevent COVID-19
Guidance for Industry
June 2020

FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency
Guidance for Industry, Investigators, and Institutional Review Boards
March 2020 – Updated June 2, 2020

Coronavirus Treatment Acceleration Program (CTAP)
March 31, 2020

Guidance on the Management of Clinical Trials During the COVID-19 (Coronavirus) Pandemic
Guidance to Sponsors on How to Manage Clinical Trials During the COVID-19 Pandemic
March 20, 2020

FDA Urges Clinical Researchers to go Virtual in Response to COVID-19 Pandemic
March 18, 2020

Considerations to Support Clinical Trial Monitoring Oversight During COVID-19
March 13, 2020

The Importance of Decentralized Clinical Trials

For the patients we pledge to serve, there is #NoGoingBack

As an industry, we learned bold new ways to conduct trials due to COVID-19. Now that we have seen the future so clearly, there is no going back. Whether you work at a sponsor, site, provider, advocacy group or other healthcare organization, please join in the mission to keep trials moving forward. Make the pledge today and have your name posted in support of #NoGoingBack.

‘No going back’ for clinical trials after COVID

Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result. The next step is ensuring the industry does not regress to old ways of working once the pandemic is over, say Karen McIntyre and Allyson Small.

COVID-19 Partnership Resource Exchange

Many of SCRS’ partners have taken action to support the site community as you navigate the COVID-19 pandemic. SCRS has created the COVID-19 Partnership Resource Exchange so that you have access to these resources in one easy-to-navigate place. Many organizations have created their own COVID-19 resource pages – we encourage you to check out what each company is doing to support the clinical research industry. Check back regularly for updates from new partners.

SCRS Virtual Summit Series

COVID-19 has had a tremendous impact on the clinical research industry. Conferences have been cancelled, travel restrictions are increasing and additional barriers are being experienced by sites, sponsors, CROs and patients alike.

SCRS recognizes the need for continuing education opportunities in light of the extensive clinical research conference cancellations due to COVID-19. In response, we have created an
8-part, complimentary Virtual Summit Series which will provide the opportunity to obtain needed education and gain a deeper understanding of how this globally adverse situation is affecting sites.

Topics covered included site preparedness for COVID-19, business development, decentralized clinical trials (DCTs), disaster planning, becoming the site of choice and more.

Sponsored by VirTrial

Questions and Answers from 03/24/2020 Site Panel – COVID-19 Preparedness – What is Happening Now

Questions and Answers from 3/31/2020 Webinar – Business Continuity: GCP Compliant Clinical Trials

Questions and Answers from 4/9/2020 Webinar – Relationship Building and How to Get More Business

Questions and Answers from 4/16/2020 Webinar – COVID-19 Site Impact Panel, Part 2: A Reflection and Best Practices for the Future

Questions and Answers from 4/21/2020 Webinar – A Good Site is Not Hard to Find

SCRS Talks Interview Series

Our partners have important updates that SCRS knows you would love to hear about, with many topics addressing COVID-19 related challenges. These short interviews will provide insight into key industry topics, current events, new perspectives, and exciting opportunities. Click the link below to visit the SCRS Talks page.

Unintended Impact of COVID-19 on Cancer

Over the last few months, many patients have been in fear of their cancer journey. This fear had nothing to do with receiving their diagnosis or walking into a screening because of a found lump or increased risk. It wasn’t about dealing with the side effects of their chemotherapy, surgery, or radiation treatment. And, it was not caused by the stress felt when waiting for results from a significant medical test or scan. The fear was caused by our country’s myopic focus on flatting the COVID-19 curve. While we may have successfully flattened the proverbial curve, we have created a potentially larger, more dangerous shadow curve in the world of cancer.

Read the full article.

COVID-19 Global Cases Live Mapping

First shared publicly on January 22 by Johns Hopkins University, the following map was developed to “provide researchers, public health authorities, and the general public with a user-friendly tool to track the [COVID-19] outbreak as it unfolds.”

Interactive Map, click red dots for statistics and drag to see different areas of the world.

Source: Johns Hopkins Center for Systems Science and Engineering. Data sources include the World Health Organization, U.S. Centers for Disease Control and Prevention, European Center for Disease Prevention and Control, and National Health Commission of the People’s Republic of China, as well as local authorities, medical sources, and news reports.

COVID-19 Trial Status Tracker

Developed by Trial Insights, this dashboard outlines COVID-19 clinical trials including their status, and related number of supporting sponsors, investigators and drug targets.

 

Source: Trial Insight on Scientist.com. Created by Incite Advisors, Inc. – RC – 1.0.16 TRIALINSIGHTS
Click here for their sources. 

SCRS COVID-19 Site Preparedness Survey Results

The emergence of the novel Coronavirus/COVID-19 has been a true test of the Society for Clinical Research Sites’ (SCRS’) mission: to unify the voice of the global clinical research site community for greater site sustainability. On March 12th, SCRS released a survey to better understand the challenges sites are facing, their level of preparation to navigate the current global reality and site needs related to the COVID-19 pandemic. It is important that SCRS continue to be the leader in advocating for site needs and educating the clinical research industry regarding how to navigate and address the challenges our industry is facing.